The sale is small relative to market cap and appears to be a routine diversification move by a director. Monitor for actual execution on Form 4; no immediate concern given the modest size and lack of prior selling pattern.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Oct 29 $14.46entry
- T+1 · 7d ago −8.64%α −8.17% · $13.21
- T+5 · due 13h ago Pending
- T+5 · todayOpen
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Frances Arnold filed a Form 144 notice to sell 11,409 shares of Generate Biomedicines common stock, valued at approximately $184,733 based on the filing date price. The shares were acquired via restricted stock vesting on September 23, 2020, as compensation. This is an advance notice of intent to sell, not a completed transaction, and the sale may not occur.
Key Facts
- Reporting owner: Frances Arnold, a Director of Generate Biomedicines, Inc.
- Proposed sale of 11,409 shares of common stock.
- Estimated aggregate market value: $184,732.91.
- Shares acquired on 09/23/2020 via restricted stock vesting as compensation.
- Broker: Fidelity Brokerage Services LLC.
- Form 144 filed on 10/29/2026; sale proposed on same date.
- No prior sales by the reporting person in the last 3 months (indicated by 'N' in the filing).
Financial Impact
Proposed sale of 11,409 shares valued at ~$184,733, representing approximately 0.01% of the company's $1.7B market cap.
Risk Factors
- Form 144 is only an intent to sell; the transaction may not be completed.
- Insider selling, even small, can sometimes signal reduced conviction, but here the amount is negligible.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007553 |
| Document: 0001959173-26-007553-index.html | 0001959173-26-007553 |
| Document: 0001959173-26-007553.txt | 0001959173-26-007553 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 5, 2026 today | SC 13G | $14.11 | awaiting T+20 | awaiting T+20 | $14.16 (+0.35%) |
Nov 3, 2026 2d ago | Institutional Cluster | $13.85 | awaiting T+20 | awaiting T+20 | $14.16 (+2.24%) |
Oct 29, 2026 7d ago | 144 | $14.46 | awaiting T+20 | awaiting T+20 | $14.16 (−2.07%) |
Oct 13, 2026 23d ago | Press Release | $12.52 | awaiting T+20 | awaiting T+20 | $14.16 (+13.10%) |
Oct 1, 2026 5w ago | Press Release | $13.80 $15.77 | ▲ +14.28% | ▲ +13.57% | $14.16 (+2.61%) |
May 7, 2026 26w ago | 8-K | $13.59 $12.91 | ▲ +5.00% | ▲ +8.14% | $14.16 (−4.19%) |
Mar 2, 2026 35w ago | Insider Cluster | $11.93 $12.50 | ▲ +4.78% | ▲ +9.19% | $14.16 (+18.69%) |
Mar 2, 2026 35w ago | Insider Cluster | $11.93 $12.50 | ▲ +4.78% | ▲ +9.19% | $14.16 (+18.69%) |
Feb 27, 2026 35w ago | 424B4 | $12.17 $11.51 | ▲ +5.42% | ▼ −2.52% | $14.16 (−16.35%) |
Feb 27, 2026 35w ago | EFFECT | $12.65 $11.44 | ▼ −9.57% | ▼ −2.01% | $14.16 (+11.94%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers